Novo Nordisk (NVO) reportedly plans to phase out production of human insulin pens while it ramps up production of other injected diabetes medications such as Ozempic. Read more.

No­vo Nordisk said Thurs­day that it plans to even­tu­al­ly halt all of its hu­man in­sulin pen pro­duc­tion glob­al­ly, ...

Novo Nordisk is ceasing production of human insulin pens, focusing on newer obesity and diabetes injections. This shift has ...

Novo Nordisk is gradually ending production of human insulin pens, the drugmaker told Reuters, as it spends billions to ramp ...

In free and democratic societies like Canada’s, politicians do not critique the arms-length funding decisions of arts agencies, nor the productions that result from them. Why? Because political ...

This is not only a sustainability consideration but also a patient safety issue as insulin that has been stored incorrectly may not have the expected effect on blood glucose. I have had type 1 ...

Some diabetes patients this year have had trouble finding their preferred insulin brands as major drug manufacturers reported shortages of the medicine. USA TODAY set out to find out what patients ...

Janel Wright had just days left in her insulin supply in early January when a pharmacist told her there was none of the drug left to fill her prescription. Her neighborhood Fred Meyer pharmacy in ...

The first-of-its-kind study will be the first to evaluate closed-loop technology in people using Insulin Pens with Time-in-Range as a primary efficacy endpoint. SAN DIEGO, CA / ACCESSWIRE / October 23 ...

The Luna system was developed as a wearable insulin pump and alternative to insulin pen to automate the insulin delivery process. The device works with continuous glucose monitors (CGM) to calculate ...

In our October research highlights, we look at a world-first stem cell transplant which helped a person with type 1 diabetes produce insulin, and how electrical impulses could regenerate cells in ...